Your browser doesn't support javascript.
loading
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre.
Palich, Romain; Agher, Rachid; Wetshikoy, Dimoke J; Cuzin, Lise; Seang, Sophie; Soulie, Cathia; Tubiana, Roland; Valantin, Marc-Antoine; Schneider, Luminita; Pourcher, Valérie; Marcelin, Anne-Geneviève; Assoumou, Lambert; Katlama, Christine.
Afiliação
  • Palich R; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Agher R; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Wetshikoy DJ; Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Cuzin L; Martinique University Hospital, Infectious and Tropical Diseases, Fort-De-France, FWI; CERPOP, INSERM UMR1295, Paul Sabatier University, Toulouse, France; and.
  • Seang S; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Soulie C; Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Tubiana R; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Valantin MA; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Schneider L; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Pourcher V; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Marcelin AG; Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Assoumou L; Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
  • Katlama C; Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France.
J Acquir Immune Defic Syndr ; 92(2): 144-152, 2023 02 01.
Article em En | MEDLINE | ID: mdl-36257296

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Fármacos Anti-HIV Limite: Female / Humans / Male País/Região como assunto: Africa / Europa Idioma: En Revista: J Acquir Immune Defic Syndr Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Fármacos Anti-HIV Limite: Female / Humans / Male País/Região como assunto: Africa / Europa Idioma: En Revista: J Acquir Immune Defic Syndr Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França